Xenon Pharmaceuticals Inc (XENE)
Xenon to Present at the 44th Annual J.P. Morgan Healthcare Conference
GeneDx Holdings (WGSWW)
GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025
Sarepta Therapeutics Inc (SRPT)
Sarepta Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Ascendis Pharma (ASND)
Ascendis Pharma to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Estrella Immunopharma Inc. (ESLA)
Estrella Immunopharma, Inc. Announces $8.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
CRISPR Therapeutics (CRSP)
CRISPR Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Biodexa Pharmaceuticals PLC (BDRX)
Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary
GeneDx Holdings (WGS)
GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025
Avantor Inc. (AVTR)
Avantor, Inc. - Avantor® to Participate in 44th Annual J.P. Morgan Healthcare Conference
Goodrx Holdings Inc (GDRX)
GoodRx Now Offers Novo Nordisk’s Cash Price for the Launch of the Wegovy® Pill